Alkem Laboratories Ltd share price logo

Alkem Laboratories Ltd (ALKEM)

₹51030.26%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Performance

  • Day's Low

    ₹5,102.2
    ₹5,103
  • 52 Week's Low

    52 Week's High

    ₹3,307.2
    ₹5,578.8
1 Month Return-1.8 %
3 Month Return+ 2.09 %
1 Year Return+ 50.9 %
Previous Close₹5,089.70
Open₹5,102.20
Volume1.12L
Upper Circuit-
Lower Circuit-
Market Cap₹60,855.00Cr

Analyst Rating

based on 22 analysts

HOLD
40.91%
Buy
27.27%
Hold
31.82%
Sell

Based on 22 analysts offering long term price targets for Alkem Laboratories Ltd. An average target of ₹5152.18

Source: S&P Global Market Intelligence

Company Information

Alkem Laboratories Ltd is a leading pharmaceutical company founded in 1973 by Mr. Samir C. Desai.

With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.

Share Price: ₹5103.00 per share as on 14 Jun, 2024 11:53 AM
Market Capitalisation: ₹60,855.00Cr as of today
Revenue: ₹2,935.82Cr as on March 2024 (Q1 24)
Net Profit: ₹304.48Cr as on March 2024 (Q1 24)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
OrganisationAlkem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Alkem Laboratories Ltd

  • Alkem Laboratories Reduces Dividend to Rs 5.00 - 13 Jun, 2024

    Alkem Laboratories has announced a reduction in dividend to Rs 5.00, despite easily covering it before the announcement. However, with an expected EPS expansion of 47.5%, there is potential for future dividend growth.

  • Alkem Laboratories Ltd Up 0.57% on NSE - 11 Jun, 2024

    Alkem Laboratories Ltd is up 0.57% on the NSE, trading at Rs 5060.05 as of 12:44 IST. The stock has gained 51.16% in the last year compared to a 25.46% increase in the NIFTY and a 54.03% rise in the Nifty Pharma.

  • Alkem Laboratories Ltd Up for Third Straight Session - 07 Jun, 2024

    Alkem Laboratories Ltd is up 1.6% on the NSE, while the benchmark NIFTY and Sensex are up around 1.78% and 1.87%, respectively. The stock has dropped around 4.49% in the last month with a PE of 32.03 based on TTM earnings ending March 24.

  • Alkem Laboratories Misses Revenue and EPS Estimates - 02 Jun, 2024

    Alkem Laboratories' full-year 2024 results show a revenue and earnings per share miss of 1.9% compared to analyst estimates. The company's shares have dropped by 12% from a week ago, with a forecasted growth rate of 8.8% p.a. for the next three years.

  • Mixed Results for Alkem Laboratories - 01 Jun, 2024

    Alkem Laboratories' Q4 results show significant YoY profit growth, but a decline in revenue compared to the previous quarter. Analysts maintain a Hold rating following the company's credible full-year report.

  • Mixed Sentiments for Alkem Labs Post Q4 Results - 30 May, 2024

    Alkem Laboratories reported a four-fold increase in consolidated net profit for Q4FY24 but saw its stock decline by over 9%. Jefferies maintained an underperform call with a target price of Rs 4,200 while Nuvama Research downgraded the stock's rating to hold from buy and reduced its target price to Rs 5,730. The company's revenue growth guidance for FY25 was cited as conservative.

  • Alkem Labs Reports Strong Q4 Results - 29 May, 2024

    Alkem Laboratories reported a consolidated net profit of Rs 293.56 crore in Q4FY24, up 313% YoY, with a modest YoY revenue increase of 1.1%. The company also recommended a final dividend of Rs 5 per share for FY24.

  • Alkem Laboratories Ltd Positioned for Strong Earnings Growth - 22 May, 2024

    Despite a high P/E ratio of 40.5x, Alkem Laboratories is expected to see earnings growth of 32% in the next year, leading shareholders to remain confident in future earnings.

  • Alkem Laboratories Ltd Up 1.6% on NSE - 17 May, 2024

    Alkem Laboratories Ltd is up 1.6% on the NSE, with a 62.44% gain in the last year compared to a 23.95% gain in NIFTY and a 54.96% gain in the Nifty Pharma index. The stock has a PE of 36.97 based on TTM earnings ending December 2023.

Insights on Alkem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 8.49% to 9.11% in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 123.1% return, outperforming this stock by 65.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 56.74% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 104.9% return, outperforming this stock by 54.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 620.52 Cr → 293.56 Cr (in ₹), with an average decrease of 27.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.50K Cr → 3.02K Cr (in ₹), with an average decrease of 7.0% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.08% to 11.92% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ALKEM stock has moved down by -1.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 18.86% to 18.52% in Mar 2024 quarter

Alkem Laboratories Ltd Valuation

Alkem Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (20.07x)

March 24, 2021

Today (33.89x)

June 13, 2024

Industry (64.96x)

June 13, 2024

Highest (44.21x)

August 9, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
DSP Midcap Fund Direct Plan GrowthDSP Midcap Fund Direct Plan Growth3.56%
Axis Midcap Fund Direct Plan GrowthAxis Midcap Fund Direct Plan Growth1.39%
Nippon India Growth Fund - Direct Plan - GrowthNippon India Growth Fund - Direct Plan - Growth1.36%
ICICI Prudential Large & Mid Cap Fund Direct Plan GrowthICICI Prudential Large & Mid Cap Fund Direct Plan Growth2.4%
ICICI Prudential Multi-Asset Fund Direct Plan GrowthICICI Prudential Multi-Asset Fund Direct Plan Growth0.75%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
56.74%
0.00
Foreign Institutions
9.11%
0.00
Mutual Funds
11.92%
0.00
Retail Investors
18.52%
0.00
Others
3.71%
0.00

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Alkem Laboratories Ltd shares.

Alkem Laboratories Ltd (ALKEM) share price today is ₹5103

Alkem Laboratories Ltd is listed on NSE

Alkem Laboratories Ltd is listed on BSE

  • Today’s highest price of Alkem Laboratories Ltd is ₹5103.
  • Today’s lowest price of Alkem Laboratories Ltd is ₹5102.2.

PE Ratio of Alkem Laboratories Ltd is 33.89

PE ratio = Alkem Laboratories Ltd Market price per share / Alkem Laboratories Ltd Earnings per share

Today’s traded volume of Alkem Laboratories Ltd(ALKEM) is 1.12L.

Today’s market capitalisation of Alkem Laboratories Ltd(ALKEM) is ₹60855Cr.

Alkem Laboratories Ltd(ALKEMPrice
52 Week High
₹5578.8
52 Week Low
₹3307.2

Alkem Laboratories Ltd(ALKEM) share price is ₹5103. It is down -8.53% from its 52 Week High price of ₹5578.8

Alkem Laboratories Ltd(ALKEM) share price is ₹5103. It is up 54.30% from its 52 Week Low price of ₹3307.2

Alkem Laboratories Ltd(ALKEMReturns
1 Day Returns
13.3%
1 Month Returns
-1.8%
3 Month Returns
2.09%
1 Year Returns
50.9%